id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-V-2350-0003,FDA,FDA-2020-V-2350,Variance Approval Letter from FDA CDRH to Jurijus Voronovas,Other,Approval for Variance (VRA),2021-06-21T04:00:00Z,2021,6,2021-06-21T04:00:00Z,,2021-06-21T14:10:50Z,,0,0,0900006484b9b353
FDA-2020-V-2350-0001,FDA,FDA-2020-V-2350,Variance Application from Jurijus Voronovas,Other,Application for Variance (VAR),2020-12-29T05:00:00Z,2020,12,2020-12-29T05:00:00Z,,2020-12-29T14:41:00Z,,0,0,09000064849cb3a9
FDA-2020-V-2350-0002,FDA,FDA-2020-V-2350,Acknowledgment Letter from FDA DMS to Jurijus Voronovas,Other,Acknowledgement Letter/Receipt,2020-12-29T05:00:00Z,2020,12,2020-12-29T05:00:00Z,,2020-12-29T14:46:47Z,,0,0,09000064849cbccc